 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
1 to 7 of 7 results |
|
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
Copani A. on PAPER: Varvel NH. et al., 2009, Evidence exists that cell death seen in AD arises from neurons attempting to divide, and this is... 24 Nov 2009.
|
 |
 |
 |
 |
 |
Copani A. on NEWS: Amyloid-β—Turning Neurogenesis Into Neurogenocide?, This paper by He and Shen is of great interest for several reasons. The first is that the... 28 May 2009.
|
 |
 |
 |
 |
 |
Copani A. on LIVE DISCUSSION: Meet New Players, Histone Deacetylase and Sirtuin—Will They Help the Cell Cycle, DNA Repair, and Gene Expression Break Into Alzheimerology’s Major League?, By using the p25 transgenic model of neurodegeneration, Kim and colleagues provide convincing... 10 Feb 2009.
|
 |
 |
 |
 |
 |
Copani A. on PAPER: Höglinger GU. et al., 2007, This interesting paper continues the series of studies suggesting that cell cycle reactivation... 19 Mar 2007.
|
 |
 |
 |
 |
 |
Copani A. on LIVE DISCUSSION: Cell Cycle Hypothesis Pedaling into Mainstream Acceptance? Results in Fly, Mouse Models Warrant a Second Look, Surely, the paper by Khurana et al. supports the hypothesis that cell cycle reactivation in... 6 Mar 2006.
|
 |
 |
 |
 |
 |
Copani A. on NEWS: Adult Neurogenesis—A Win Wnt Situation?, The canonical Wnt signaling pathway has multiple roles in stem/progenitor cells. In embryonic... 1 Nov 2005.
|
 |
 |
 |
 |
 |
Copani A. on NEWS: ATM Links DNA Damage to Neuronal Cell Cycle Activation and Apoptosis, Cell Cycle Signaling, DNA Damage and Neuronal Apoptosis
Three years ago, following... 1 Mar 2004.
|
 |
 |
 |
 |
 |
 |
1 to 7 of 7 results |
|
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Should the FDA be allowed to use data from overseas clinical trials? |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Absolutely, we are running out of viable subjects in the U.S. |
 |
 |
 |
 |
 |
 |
9 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Yes, so long as the data is reliable |
 |
 |
 |
 |
 |
 |
31 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the trials are not as rigorous |
 |
 |
 |
 |
 |
 |
3 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the data should be repeated in the U.S. |
 |
 |
 |
 |
 |
 |
5 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the drug sponsors are just trying to cut corners |
 |
 |
 |
 |
 |
 |
3 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Responses: 51 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
|
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Archived Polls |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |

|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |